Table 6 Comparison of laboratory indices between hypertensive COVID-19 patients with and without other comorbidities

6.77 (5.04–9.61)

8.63 (5.19–12.55)

7.94 (5.71–9.31)

0.156

5.36 (3.56–7.98)

7.96 (3.61–11.51)

6.22 (4.44–8.17)

0.128

0.78 (0.55–1.17)

0.56 (0.35–0.73)

0.72 (0.58–1.07)

0.585

6.36 (2.99–14.59)

15.77 (4.16–33.17)

8.26 (4.49–13.04)

0.148

94.5 (89.0–97.0)

87.0 (85.0–96.6)

93.8 (87.0–97.7)

0.071

11.8 (9.2–16.2)

12.0 (10.4–19.6)

11.2 (10.1–14.2)

0.791

33.0 (19.0–57.5)

56.0 (26.0–128.0)

69.5 (35.8–107.3)

0.160

34.5 (24.0–56.3)

40.0 (31.0–78.0)

54.5 (48.0–80.5)

0.740

31.9 (29.4–35.5)

30.8 (27.0–31.9)

35.7 (30.8–38.3)

0.502

31.7 (28.3–35.7)

31.9 (29.4–35.9)

30.7 (28.9–33.6)

0.331

306 (217–429)

424 (306–497)

331 (243–459)

0.350

72.50 (60.70–95.18)

72.30 (54.20–110.40)

92.05 (70.18–151.88)

0.167

49.0 (35.3–69.0)

55.0 (37.0–89.0)

56.5 (39.3–72.5)

0.962

35.3 (6.1–124.3)

68.0 (24.8–180.0)

81.0 (26.7–145.2)

0.548

778.27 (463.77–1301.59)

1101.76 (680.05–2100.00)

915.17 (413.27–1437.52)

0.726

10.43 (7.05–13.71)

11.64 (7.11–12.41)

10.54 (9.41–14.60)

0.636

72.5 (31.1–174.3)

72.5 (31.1–75.5)

51.2 (28.7–126.5)

0.047

0.99 (0.55–3.37)

1.48 (0.69–2.67)

0.90 (0.35–2.89)

0.369

4.00 (2.99–5.15)

4.90 (4.10–6.20)

5.25 (3.63–7.70)

0.537

11.3 (10.4–12.2)

11.1 (10.2–12.5)

11.4 (10.4–12.4)

0.320

26.5 (23.6–31.5)

23.4 (20.0–30.2)

25.1 (23.5–31.7)

0.635